December 07, 2023
The Federal Circuit has backed a decision that a slew of generic-drug makers don't infringe two of H. Lundbeck's patents on antidepressant drug Trintellix, while also affirming a decision that Lupin Pharmaceuticals Inc. infringes another patent.